Systemic toxicity after isolated limb perfusion with melphalan for melanoma

This publication has 43 references indexed in Scilit:

• Surgical limb perfusion for extremity melanoma
  Surgical Oncology, 1994
• Treatment of primary or relapsing limb cancer by isolation perfusion with high-dose alpha-tumor necrosis factor, gamma-interferon, and melphalan
  Cancer, 1994
• Isolated limb perfusion for melanoma: Effectiveness and toxicity of cisplatin compared with that of melphalan and other drugs
  World Journal of Surgery, 1992
• Hyperthermic isolated perfusion with melphalan in the treatment of advanced malignant melanoma of the lower limb
  British Journal of Surgery, 1990
• Seven years experience with hyperthermic perfusions in extracorporeal circulation for melanoma of the extremities
  Journal of Surgical Oncology, 1989
• Prognostic variables in recurrent limb melanoma treated with hyperthermic antiblastic perfusion
  Cancer, 1989
• Toxicity and complications of vascular isolation and hyperthermic perfusion with lmidazole carboxamide (DTIC) in melanoma
  Cancer, 1986
• A clinical and pharmacokinetic study of isolated limb perfusion with heat and melphalan for melanoma
  Cancer, 1985
• Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions
  European Journal of Cancer and Clinical Oncology, 1982
• Experience with 1-phenylalanine mustard dihydrochloride in isolation-perfusion of extremities for malignant melanoma
  Cancer, 1971